SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sinem Tunc, Julia Graf, Vera Tadic, Norbert Brüggemann, Alexander Schmidt, Mohamed Al-Khaled, Simone Wolff, Eva-Juliane Vollstedt, Anne Lorwin, Jennie Hampf, Linda Piskol, Christine Klein, Johann Hagenah, Meike Kasten, A population-based study on combined markers for early Parkinson's disease, Movement Disorders, 2015, 30, 1
  2. 2
    Opeyemi O. Daramola, Samuel S. Becker, An algorithmic approach to the evaluation and treatment of olfactory disorders, Current Opinion in Otolaryngology & Head and Neck Surgery, 2015, 23, 1, 8

    CrossRef

  3. 3
    Diane B. Miller, James P. O’Callaghan, Biomarkers of Parkinson’s disease: Present and future, Metabolism, 2015, 64, 3, S40

    CrossRef

  4. 4
    Anette Schrag, Laura Horsfall, Kate Walters, Alastair Noyce, Irene Petersen, Prediagnostic presentations of Parkinson's disease in primary care: a case-control study, The Lancet Neurology, 2015, 14, 1, 57

    CrossRef

  5. 5
    Jose-Alberto Palma, Horacio Kaufmann, Autonomic disorders predicting Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, S94

    CrossRef

  6. You have free access to this content6
    Lama M. Chahine, Matthew B. Stern, Characterizing Premotor Parkinson's Disease: Clinical Features and Objective Markers, Movement Disorders Clinical Practice, 2014, 1, 4
  7. 7
    Inga Liepelt-Scarfone, Stefanie Lerche, Stefanie Behnke, Jana Godau, Alexandra Gaenslen, Christoph Pausch, Klaus Fassbender, Kathrin Brockmann, Karin Srulijes, Heiko Huber, Isabel Wurster, Daniela Berg, Clinical characteristics related to worsening of motor function assessed by the Unified Parkinson’s Disease Rating Scale in the elderly population, Journal of Neurology, 2014,

    CrossRef

  8. 8
    H. C. V. Pfeiffer, A. Løkkegaard, M. Zoetmulder, L. Friberg, L. Werdelin, Cognitive impairment in early-stage non-demented Parkinson's disease patients, Acta Neurologica Scandinavica, 2014, 129, 5
  9. 9
    Qian Xiao, Sheng Chen, Weidong Le, Hyposmia: a possible biomarker of Parkinson’s disease, Neuroscience Bulletin, 2014, 30, 1, 134

    CrossRef

  10. 10
    Honglei Chen, Xuemei Huang, Xuguang Guo, Shyamal Peddada, Individual and joint prevalence of three nonmotor symptoms of PD in the US general population, Movement Disorders, 2014, 29, 10
  11. 11
    Erika Driver-Dunckley, Charles H. Adler, Joseph G. Hentz, Brittany N. Dugger, Holly A. Shill, John N. Caviness, Marwan N. Sabbagh, Thomas G. Beach, Olfactory dysfunction in incidental Lewy body disease and Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, 11, 1260

    CrossRef

  12. 12
    Laura Silveira-Moriyama, Andrew J. Lees, Parkinson disease: How reliable are prodromal indicators of Parkinson disease?, Nature Reviews Neurology, 2014, 11, 1, 5

    CrossRef

  13. 13
    A. J. Noyce, J. P. Bestwick, L. Silveira-Moriyama, C. H. Hawkes, C. H. Knowles, J. Hardy, G. Giovannoni, S. Nageshwaran, C. Osborne, A. J. Lees, A. Schrag, PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results, Journal of Neurology, Neurosurgery & Psychiatry, 2014, 85, 1, 31

    CrossRef

  14. 14
    Uwe Walter, Robert Heilmann, Lara Kaulitz, Tino Just, Bernd Joachim Krause, Reiner Benecke, Jacqueline Höppner, Prediction of Parkinson’s disease subsequent to severe depression: a ten-year follow-up study, Journal of Neural Transmission, 2014,

    CrossRef

  15. 15
    Jennifer G. Goldman, Ron Postuma, Premotor and nonmotor features of Parkinsonʼs disease, Current Opinion in Neurology, 2014, 27, 4, 434

    CrossRef

  16. 16
    Stefanie Lerche, Klaus Seppi, Stefanie Behnke, Inga Liepelt-Scarfone, Jana Godau, Philipp Mahlknecht, Alexandra Gaenslen, Kathrin Brockmann, Karin Srulijes, Heiko Huber, Isabel Wurster, Heike Stockner, Stefan Kiechl, Johann Willeit, Arno Gasperi, Klaus Fassbender, Werner Poewe, Daniela Berg, Risk factors and prodromal markers and the development of Parkinson’s disease, Journal of Neurology, 2014, 261, 1, 180

    CrossRef

  17. 17
    Katja Hagen, Ann-Christine Ehlis, Florian B. Haeussinger, Stefan Beeretz, Gina V. Kromer, Sebastian Heinzel, Walter Maetzler, Gerhard W. Eschweiler, Daniela Berg, Andreas J. Fallgatter, Florian G. Metzger, The relation of SMI and the VSEP in a risk sample for neurodegenerative disorders, Journal of Neural Transmission, 2014,

    CrossRef

  18. 18
    N. Zokaei, A. McNeill, C. Proukakis, M. Beavan, P. Jarman, P. Korlipara, D. Hughes, A. Mehta, M. T. M. Hu, A. H. V. Schapira, M. Husain, Visual short-term memory deficits associated with GBA mutation and Parkinson's disease, Brain, 2014, 137, 8, 2303

    CrossRef

  19. 19
    Philipp Mahlknecht, Werner Poewe, Defining premotor Parkinson’s disease: a window of opportunity for neuroprotection?, Neurodegenerative Disease Management, 2013, 3, 1, 61

    CrossRef

  20. 20
    Philipp Mahlknecht, Werner Poewe, Is there a need to redefine Parkinson’s disease?, Journal of Neural Transmission, 2013, 120, S1, 9

    CrossRef

  21. 21
    Amy W. Amara, David G. Standaert, Metabolomics and the search for biomarkers in Parkinson's disease, Movement Disorders, 2013, 28, 12
  22. 22
    Alex Iranzo, Eduard Tolosa, Ellen Gelpi, José Luis Molinuevo, Francesc Valldeoriola, Mónica Serradell, Raquel Sanchez-Valle, Isabel Vilaseca, Francisco Lomeña, Dolores Vilas, Albert LLadó, Carles Gaig, Joan Santamaria, Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study, The Lancet Neurology, 2013, 12, 5, 443

    CrossRef

  23. 23
    Alex Iranzo, Parkinson Disease and Sleep: Sleep–Wake Changes in the Premotor Stage of Parkinson Disease; Impaired Olfaction and Other Prodromal Features, Current Neurology and Neuroscience Reports, 2013, 13, 9

    CrossRef

  24. 24
    David T. Dexter, Peter Jenner, Parkinson disease: from pathology to molecular disease mechanisms, Free Radical Biology and Medicine, 2013, 62, 132

    CrossRef

  25. 25
    Uwe Walter, Sabine Kleinschmidt, Florian Rimmele, Christian Wunderlich, Irene Gemende, Reiner Benecke, Knut Busse, Potential impact of self-perceived prodromal symptoms on the early diagnosis of Parkinson’s disease, Journal of Neurology, 2013, 260, 12, 3077

    CrossRef

  26. 26
    A. J. Clark, B. Ritz, E. Prescott, N. H. Rod, Psychosocial risk factors, pre-motor symptoms and first-time hospitalization with Parkinson's disease: a prospective cohort study, European Journal of Neurology, 2013, 20, 8
  27. 27
    Connie Marras, Parkinson’s Disease: Medical and Surgical Treatment, 2013,

    CrossRef

  28. 28
    Daniela Berg, Werner Poewe, Can we define “pre-motor” Parkinson's disease?, Movement Disorders, 2012, 27, 5
  29. 29
    Johannes R. Streffer, Igor D. Grachev, Cheryl Fitzer-Attas, Baltazar Gomez-Mancilla, Babak Boroojerdi, Juliana Bronzova, Susanne Ostrowitzki, Stephen J. Victor, Paulo Fontoura, Robert Alexander, Prerequisites to launch neuroprotective trials in Parkinson's disease: An industry perspective, Movement Disorders, 2012, 27, 5